Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-179414
Filing Date
2015-05-08
Accepted
2015-05-08 15:23:28
Documents
14
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d924919d10q.htm 10-Q 193223
2 EX-10.1 d924919dex101.htm EX-10.1 8702
3 EX-10.2 d924919dex102.htm EX-10.2 8678
4 EX-10.3 d924919dex103.htm EX-10.3 4676
5 EX-10.4 d924919dex104.htm EX-10.4 6848
6 EX-31.1 d924919dex311.htm EX-31.1 8884
7 EX-31.2 d924919dex312.htm EX-31.2 9236
8 EX-32.1 d924919dex321.htm EX-32.1 5360
  Complete submission text file 0001193125-15-179414.txt   2283161

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT hrtx-20150331.xml EX-101.INS 282140
10 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20150331.xsd EX-101.SCH 21891
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20150331_cal.xml EX-101.CAL 17136
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20150331_def.xml EX-101.DEF 147935
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20150331_lab.xml EX-101.LAB 144870
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20150331_pre.xml EX-101.PRE 156877
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 15846321
SIC: 2834 Pharmaceutical Preparations